about
The effects of psychostimulant drugs on blood brain barrier function and neuroinflammationComparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugsMethamphetamine-associated psychosis.In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the ratDual dopamine/serotonin releasers: potential treatment agents for stimulant addictionA receptor mechanism for methamphetamine action in dopamine transporter regulation in brainDual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictionsTrace amine-associated receptor 1 as a monoaminergic modulator in brainEffects of cocaine self-administration history under limited and extended access conditions on in vivo striatal dopamine neurochemistry and acoustic startle in rhesus monkeys.Norepinephrine and stimulant addictionComparative potencies of 3,4-methylenedioxymethamphetamine (MDMA) analogues as inhibitors of [3H]noradrenaline and [3H]5-HT transport in mammalian cell linesNeurotransmitter transporters and their impact on the development of psychopharmacologyModulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addictionBinding of an octylglucoside detergent molecule in the second substrate (S2) site of LeuT establishes an inhibitor-bound conformationTDIQ (5,6,7,8-tetrahydro-1,3-dioxolo [4,5-g]isoquinoline): discovery, pharmacological effects, and therapeutic potentialBalance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugsRecognition of psychostimulants, antidepressants, and other inhibitors of synaptic neurotransmitter uptake by the plasma membrane monoamine transportersDuloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory studyThermostabilization of the Human Serotonin Transporter in an Antidepressant-Bound ConformationA substrate trapping mutant form of striatal-enriched protein tyrosine phosphatase prevents amphetamine-induced stereotypies and long-term potentiation in the striatumNeonatal exposure to amphetamine alters social affiliation and central dopamine activity in adult male prairie volesClassic Studies on the Interaction of Cocaine and the Dopamine TransporterThe preclinical pharmacology of mephedrone; not just MDMA by another name.Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamineWithdrawal from extended-access cocaine self-administration results in dysregulated functional activity and altered locomotor activity in rats.Rapid EEG desynchronization and EMG activation induced by intravenous cocaine in freely moving rats: a peripheral, nondopamine neural triggering.Assessing the ability of sequence-based methods to provide functional insight within membrane integral proteins: a case study analyzing the neurotransmitter/Na+ symporter family.The roles of dopamine transport inhibition and dopamine release facilitation in wake enhancement and rebound hypersomnolence induced by dopaminergic agents.Behavioral genetic contributions to the study of addiction-related amphetamine effects.Functional and structural brain changes associated with methamphetamine abuseNeuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related AnalogsThe role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals.Serotonin reuptake transporter deficiency modulates the acute thermoregulatory and locomotor activity response to 3,4-(±)-methylenedioxymethamphetamine, and attenuates depletions in serotonin levels in SERT-KO rats.Partial regulation of serotonin transporter function by gamma-synuclein.Aripiprazole effects on self-administration and pharmacodynamics of intravenous cocaine and cigarette smoking in humansRole of the serotonergic system in reduced pulmonary function after exposure to methamphetamine.The effects of concurrent administration of +/-3,4-methylenedioxymethamphetamine and cocaine on conditioned place preference in the adult male rat.Interrelation of dopamine transporter oligomerization and surface presence as studied with mutant transporter proteins and amphetamine.Characterization of a novel and potentially lethal designer drug (±)-cis-para-methyl-4-methylaminorex (4,4'-DMAR, or 'Serotoni').Novel pharmacotherapeutic treatments for cocaine addiction.
P2860
Q21129283-32146436-BD33-4187-AADF-1E0DEB684E9CQ21262013-9F265FF0-5376-495C-8E36-49CB7123C4ECQ24632172-A365D2DF-6C88-44BD-9A8A-E64F3131A631Q24632527-123EE9BE-84CA-44C4-960D-62375DD2AFEFQ24641896-F7BABA1C-C058-4A6E-9AE0-F23BEE0EF9CEQ24642179-4FD45B12-1155-47C4-977A-CF7B3153412DQ24647786-B87A7BC3-087E-426A-93E5-71F311F6A2DBQ24650242-438FED21-FC4F-4A5B-841F-732D138A8685Q24655301-811034E7-B0C3-41FC-982B-D01626E1B661Q24656833-496C7A32-59CE-4FCB-B16B-ECA55BC2D8DBQ24670108-F24C362D-51B3-42B5-ACFF-723167A857CDQ24670273-CE7BD03F-7387-4683-BF49-00AA3C2FAF45Q27014154-D7E88DB6-612F-4C53-A8D4-E5AB258FE61EQ27654242-F141E696-4B9A-426A-BF2D-B33DDE84794AQ28260961-CACF4409-F53D-4998-8924-8ECAAB48903FQ28274119-3C255FB5-D4DD-46F7-98CF-9599D9E4C4B4Q28476265-D5AFD982-1F67-49B3-A969-C2F258984556Q28483370-4F0DE66E-D296-46B8-924F-924B81DF2C9EQ28551699-483A7377-C92C-4C7E-866E-E80B14B62975Q28573319-DF70CC97-0E0B-4175-92C7-14CE2DFE62FAQ30371463-2995CBC4-5A60-40BB-961C-8F46C868ED44Q30397145-5F704330-8F1F-4083-A861-ECFADC44D583Q30412911-BF1466B0-B202-4CD3-A540-A890C469F72FQ30417935-9C15DC31-7579-497A-889B-769491A78C47Q30423895-FC7E5E01-38B4-43A7-B4B2-3252A91C325EQ30477187-66E76A46-D113-4E20-AD2B-71226D965EA5Q30481053-56078159-E2AB-4F13-BDE8-275430D44B73Q30481775-05BE3177-37F3-4B65-84ED-0FD56863D6C1Q30494693-8397AF13-C9A4-4408-9407-7607EB946F98Q30833169-992E4809-83D5-4D1F-B912-0F6644D997F8Q33566201-E6BEDABA-ED0C-47CB-AB01-6B3E28065E1BQ33598487-B1E27082-C879-465E-B983-1CD3ADFC3399Q33652473-89164EE5-5566-440C-BEB9-46B453EE9C64Q33674814-07FA1AA9-B8DF-45AC-BE79-9A3E631306F7Q33841432-DE26687C-1D10-4843-8445-5D596E5D4922Q33868543-F9557967-A268-4E7C-A6F2-5B0804BD59D8Q33883665-C6A45DF1-D366-4C5C-B787-2435390DBC0BQ34020736-1AD6BE35-5778-4128-8C8E-B2BD7BD8C97DQ34027074-F6E7DE73-A154-4163-ADB0-8B5A82A62E7EQ34065088-924017B8-473E-43D7-92F9-AD3CFCDF76A7
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Monoamine transporters and psychostimulant drugs.
@ast
Monoamine transporters and psychostimulant drugs.
@en
type
label
Monoamine transporters and psychostimulant drugs.
@ast
Monoamine transporters and psychostimulant drugs.
@en
prefLabel
Monoamine transporters and psychostimulant drugs.
@ast
Monoamine transporters and psychostimulant drugs.
@en
P1476
Monoamine transporters and psychostimulant drugs.
@en
P2093
Michael H Baumann
Richard B Rothman
P356
10.1016/J.EJPHAR.2003.08.054
P407
P577
2003-10-01T00:00:00Z